Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myocet-based chemotherapy for cerebral lymphoma
2012-002308-41Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- May 2013
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of doxorubicin in primary central nervous system lymphoma (PCNSL) and central nervous system lymphoma, sponsored by Centre Hospitalier Universitaire de Brest. Started May 2013; status: active.
02
Drugs
doxorubicin
03
Conditions
primary central nervous system lymphoma (PCNSL)central nervous system lymphoma
Beyond the preview
Go deeper on 2012-002308-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002308-41.